2Fang Z Y,Prins J B,Marwick T H.Diabetic cardiomyopathy:evidence,mechanisms,and therapeutic implcations[J].Endocr Rev,2004,25(4):543-67. 被引量：1
3Li C Y,Cao L S,Zeng Q T,et al.Taurine may prevent diabetiv rats from developing cardiomyopathy also by downregulating angiotensinⅡtype2 receptor expression[J].Cardiovasc Drugs Ther,2005,19(2):105-12. 被引量：1
4Yue T L,Bao W,Gu J L,et al.Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury[J].Diabetes,2005,54(2):554-62. 被引量：1
5Ghosh S,Qi D,An D,et al.Brief episode of STZ-induced hyperglycemia produces cardiac abnormalities in rats fed a diet rich in n-6 PUFA[J].Am J Physiol Heart Circ Physiol,2004,287(6):2518-27. 被引量：1
6Malhotra A,Begley R,Kang B P,et al.PKC-{epsilon}-dependent survival signals in diabetic hearts[J].Am J Physiol Heart Circ Physiol,2005,289(4):H1343-50. 被引量：1
7Asai T,Okumura K,Takahashi R,et al.Combined therapy with PPARalpha agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency[J].Cardiovasc Res,2006,70(3):566-77. 被引量：1
8Burkart E M,Sambandam N,Han X,et al.Nuclear receptors PPARβ/δ and PPARα direct distinct metabolic regulatory programs in the mouse heart[J].J Clin Invest,2007,117(12):3930-9. 被引量：1
9Vikramadithyan R K,Hirata K,Yagyu H,et al.Peroxisome proliferator-activated receptor agonists modulate heart function in transgenic mice with lipotoxic cardiomyopathy[J].J Pharmacol Exp Ther,2005,313(2):586-93. 被引量：1
10Gilde A J,van der Lee K A,Willemsen P H,et al.Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta,but not PPARgamma,modulate the expression of genes involved in cardiac lipid metabolism[J].Circ Res,2003,92(5):518-24. 被引量：1
